APA (7th ed.) Citation

Liao, K., Chen, C., Chen, C., & Chen, C. (2024, February). Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: Results of a retrospective analysis of a large insurance database in Taiwan. Frontiers in Pharmacology.

Chicago Style (17th ed.) Citation

Liao, Kuang-Ming, Chung-Yu Chen, Chung-Yu Chen, and Chung-Yu Chen. "Risk of Potential Hepatotoxicity from Pirfenidone or Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Results of a Retrospective Analysis of a Large Insurance Database in Taiwan." Frontiers in Pharmacology Feb. 2024.

MLA (9th ed.) Citation

Liao, Kuang-Ming, et al. "Risk of Potential Hepatotoxicity from Pirfenidone or Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Results of a Retrospective Analysis of a Large Insurance Database in Taiwan." Frontiers in Pharmacology, Feb. 2024.